Diagnosis and treatment of bipolar disorder in children and adolescents

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 15, 2004, Pages 30-34

  Wagner, Karen Dineen ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGE; BIPOLAR DISORDER; CHILD; CLINICAL TRIAL; COMORBIDITY; DRUG COMBINATION; FAMILY HEALTH; FAMILY THERAPY; HUMAN; MULTIMODALITY CANCER THERAPY; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMORBIDITY; DRUG THERAPY, COMBINATION; FAMILY HEALTH; FAMILY THERAPY; HUMANS; LITHIUM; PATIENT EDUCATION; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; TREATMENT OUTCOME;

EID: 16544387069     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 1995;34:454-463
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Press; 1994
3. Leibenluft E, Charney DS, Towbin KE, et al. Defining clinical phenotypes of juvenile mania. Am J Psychiatry 2003;160:430-437
4. Geller B, Zimerman B, Williams M, et al. Diagnostic characteristics of 93 cases of prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2000;10:157-164
5. Geller B, Zimerman B, Williams M, et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacol 2002;12:11-25
6. Chang KD, Steiner H, Ketter TA. Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry 2000;39:453-460
7. Geller B, Zimerman B, Williams M, et al. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 2001;158:125-127
8. Kovacs M, Pollock M. Bipolar disorder and comorbid conduct disorder in childhood and adolescence. J Am Acad Child Adolesc Psychiatry 1995;34:715-723
9. Carlson GA, Kelly KL. Manic symptoms in psychiatrically hospitalized children: what do they mean? J Affect Disord 1998;51:123-135
10. Masi G, Toni C, Perugi G, et al. Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity. Can J Psychiatry 2001;46:797-802
11. Birmaher B, Kennah A, Brent D, et al. Is bipolar disorder specifically associated with panic disorder in youths? [CME] J Clin Psychiatry 2002;63:414-419
12. West SA, Strakowski SM, Sax KW, et al. Phenomenology and comorbidity of adolescents hospitalized for the treatment of acute mania. Biol Psychiatry 1996;39:458-460
13. Wilens TE, Biederman J, Millstein RB, et al. Risk for substance use disorders in youths with child- and adolescent-onset bipolar disorder. J Am Acad Child Adolesc Psychiatry 1999;38:680-685
14. Wozniak J, Biederman J, Mundy E, et al. A pilot family study of childhood-onset mania. J Am Acad Child Adolesc Psychiatry 1995;34:1577-1583
15. Hazell PL, Carr V, Lewin TJ, et al. Manic symptoms in young males with ADHD predict functioning but not diagnosis after 6 years. J Am Acad Child Adolesc Psychiatry 2003;42:552-560
16. Geller B, Craney JL, Bolhofner K, et al. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2002;159:927-933
17. Strober M, Schmidtlackner S, Freeman R, et al. Recovery and relapse in adolescents with bipolar affective-illness: a 5-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995;34:724-731
18. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord 2000;2:281-293
19. Wagner KD. Management of bipolar disorder in children and adolescents. Psychopharmacol Bull 2002;36:151-159
20. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435
21. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
22. Kafantaris V, Coletti DJ, Dicker R, et al. Lithium treatment of acute mania in adolescents: a large open trial. J Am Acad Child Adolesc Psychiatry 2003;42:1038-1045
23. Geller B, Cooper TB, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry 1998;37:171-178
24. Wagner KD, Weller E, Carlson G, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2002;41:1224-1230
25. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000;39:713-720
26. Kowatch RA, Carmody TJ, Suppes T, et al. Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders: a summary of two previous studies. Acta Neuropsychiatrica 2000;12:145-149
27. Reimherr JP, Rosen SJ, Leahy LF. Oxcarbazepine treatment in child and adolescent mood and anxiety disorders. Paper presented at the annual meeting of the US Psychiatric Congress; October 28-31, 2002; Las Vegas, Nev
28. Frazier JA, Biederman J, Tohen M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001;11:239-250
29. Biederman J. Open-label study of risperidone in children with bipolar disorder. Presented at the 16th annual meeting of the European Neuropsychopharmacology Congress; September 20-24, 2003; Prague, Czech Republic. Abstract P.2.079
30. DelBello MP, Schwiers ML, Rosenberg HL, et al. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41:1216-1223
31. Ryback RS, Brodasky L, Munasifi F. Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci 1997;9:301
32. Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145-148
33. Masi G, Mucci M, Millepiede S. Clozapine in adolescent inpatients with acute mania. J Child Adolesc Psychopharmacol 2002;12:93-99
34. Kowatch RA, Sethuraman G, Hume JH, et al. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry 2003;53:978-984
35. Findling RL, McNamara NK, Gracious BL, et al. Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry 2003;42:895-901
36. Strober M, Morrell W, Lampert C, et al. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry 1990;147:457-461
37. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder [Revision]. Am J Psychiatry 2000;159:1-50
38. Fristad MA, Gavazzi SM, Mackinaw-Koons B. Family psychoeducation: an adjunctive intervention for children with bipolar disorder. Biol Psychiatry 2003;53:1000-1008
39. Fristad MA, Goldberg-Arnold JS, Gavazzi SM. Multi-family psychoeducation groups in the treatment of children with mood disorders. J Marit Fam Ther 2003;29:491-504
40. Taylor DO, Miklowitz DJ, George EL, et al. Modifying focused family therapy for adolescents with bipolar disorder. Presented at the annual meeting of the Fifth International Conference on Bipolar Disorder; June 12-14, 2003; Pittsburgh, Pa. Abstract 199